US open: Stocks point to a mixed open, jobless claims disappoint
Fiona Cincotta April 8, 2021 8:39 AM
US futures point to a mixed start with tech supported by the prospect of watered down tax rises. US jobless claims unexpectedly rise.
Dow futures -0.04% at 33401
S&P futures +0.3% at 4090
Nasdaq futures +0.8% at 13721
FTSE +0.4% at 6914
Dax -0.06% at 15178
Euro Stoxx +0.3% at 3968
US futures are pointing to a stronger start with the tech heavy Nasdaq set to outperform. Stocks are being boosted by confirmation of a supportive Fed and by the prospect of Biden’s tax cuts being watered down.
The minutes from the Fed’s March meeting saw policy markets acknowledge progress in the US economic recovery, but also reiterate that the recovery would take some time. The Fed showed no intentions of tightening policy sooner than anticipated. The prospect of an ultra-loose monetary policy for longer has boosted stocks whilst pulling on the US.
Also supporting the market are reports that Biden’s corporate tax plans are less ambitious than feared with 15% minimum tax proposed by Janet Yellen, applying to companies with over $2 billion annual income, a much higher threshold than the $100 million initially proposed.
As a result of Biden’s softer tax plans, big tech are on the rise. The sector stood to be hard hit by ambitious tax plans so any suggestions that the tax hit could be lower is good news.
US jobless claims unexpectedly jump
Jobless claim unexpectedly rose last week to 744k, up from 728k previously and significantly worse than the 680k expected.
The data come following a blowout non-farm payroll report and upbeat JOLTS job opening numbers earlier in the week.
Federal Reserve Chair Jerome Powell is expected to speak later but he is not expected to add anything new to the minutes released yesterday.
Where next for the Nasdaq?
The Nasdaq trades above its 50 & 100 EMA on the 4 hour chart. The rally has gained momentum since the start the April, however the rally appears to be running out of steam. The RSI is also in overbought territory so a slight pull back could be on the cards before an attempt is made back towards the all time high of 13900 and then on to 14000. Any slip lower could meet support at 13500 this week's low and 13400 the 50 EMA. It would take a move below here to negate the upward trend.
FX – EUR rises, gains capped by AstraZeneca vaccine concerns
The US Dollar is moving southwards after the minutes from the FOMC March meeting reiterated a dovish stance and after weaker than forecast non-farm payrolls.
EUR/USD – there were few surprises from the ECB minutes as policy makers reassured that they will maintain an accommodative stance for as long as necessary. The central bank added that it saw no risk of the economy overheating. EUR/USD has had a strong rally so far this week, although gains in the pair are being capped by concerns surrounding the AstraZeneca covid vaccine in Europe. Regulators have drawn between rare blood clots and the vaccine; a covid vaccine that Europe’s already sluggish vaccine programme depends heavily on
GBP/USD +0.2% at 1.3765
EUR/USD trades +0.13% at 1.1881
Oil lower after disappointing EIA data
Oil is trending lower, snapping a two-day winning run, despite the upbeat market mood and a weaker US Dollar. A disappointing EIA crude oil inventory report is dragging on the price along with the ongoing covid concerns.
The EIA report released on Wednesday revealed a larger than expected 3.5 million barrel draw in inventories. However, gasoline stocks saw a much larger than expected rise with a build of 4.044 million.
Concerns over rising covid numbers in key developing markets such as Brazil and India are weighing on the future demand outlook. The ongoing lockdown in Europe is also a headwind.
US crude trades -0.4% at $59.50
Brent trades -0.25% at $62.87
16:00 Fed Bullard Speech
17:00 Fed Chair Jerome Powell Speech
18:00 Fed Kashkari Speech
Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.
Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.